Story perspectives

Wireless Retinal Implant Boosts Vision in 81% of Patients

3/2/2026

Summary

Story summary

The PRIMAvera trial, published in the New England Journal of Medicine, shows the wireless retinal implant improves central vision in advanced age-related macular degeneration for 81% of 32 participants after one year.
The device, developed by Daniel Palanker, converts light into electrical signals to stimulate surviving retinal cells.
The manufacturer seeks regulatory approval in Europe and the United States, noting at-home reading and a 59-letter gain after one year.

1 of 1

Story summary

The PRIMAvera trial, published in the New England Journal of Medicine, shows the wireless retinal implant improves central vision in advanced age-related macular degeneration for 81% of 32 participants after one year.
The device, developed by Daniel Palanker, converts light into electrical signals to stimulate surviving retinal cells.
The manufacturer seeks regulatory approval in Europe and the United States, noting at-home reading and a 59-letter gain after one year.